Gabelli & Co Investment Advisers’s PRA Health Sciences, Inc. PRAH Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-78,400	Closed	-$13M	–	587
2021 Q2	$13M	Buy	78,400 +4,500	+6%	+$751K	1.5%	22
2021 Q1	$11.3M	Buy	+73,900	New	+$10M	1.41%	18

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Gabelli & Co Investment Advisers's PRAH Position: Q3 2021 in Review

Gabelli & Co Investment Advisers sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 78,400 shares — an estimated $13M sold.

Gabelli & Co Investment Advisers first reported a position in PRAH in Q1 2021 and held it in 2 quarters. The position peaked at $13M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Gabelli & Co Investment Advisers reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 78,400 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $13M.
Gabelli & Co Investment Advisers first reported a position in PRA Health Sciences, Inc. in Q1 2021 and held it in 2 quarters.
Gabelli & Co Investment Advisers's PRA Health Sciences, Inc. position peaked at $13M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.